Achromobacter xylosoxidans in idiopathic cystic bronchiectasis

Anthony Simon Bates; Manjula Natarajan; Raja Vongala Reddy

doi:10.1136/bcr-2015-211610

Achromobacter xylosoxidans in idiopathic cystic bronchiectasis

Anthony Simon Bates^* (Corresponding Author), Manjula Natarajan, Raja Vongala Reddy

^*Corresponding author for this work

Medical Education

Research output: Contribution to journal › Article › peer-review

2 Citations (Scopus)

Abstract

This is the first case in the English language describing Achromobacter xylosoxidans in a patient with idiopathic bronchiectasis. A 66-year-old man with bronchiectasis presented with shortness of breath to the emergency department of our institution, a district hospital in the UK. His medications included long-term supplemental oxygen therapy and prophylactic azithromycin. Following 2 days admission to the respiratory unit, his saturations significantly deteriorated, and the patient was admitted to intensive care with type II respiratory failure. Following a week of intubation and ventilation, multidrug resistant A. xylosoxidans was isolated from the tracheal aspiration secretions. The patient recovered after receiving targeted intravenous antimicrobial therapy.

Original language	English
Article number	e211610
Journal	BMJ Case Reports
Volume	11
Issue number	1
Early online date	28 Nov 2018
DOIs	https://doi.org/10.1136/bcr-2015-211610
Publication status	Published - Nov 2018

Keywords

Achromobacter denitrificans
Aged
Anti-Bacterial Agents/administration & dosage
Bronchiectasis/drug therapy
Gram-Negative Bacterial Infections/drug therapy
Humans
Male

Access to Document

10.1136/bcr-2015-211610Licence: Unspecified

Fingerprint Dive into the research topics of '<i>Achromobacter xylosoxidans</i> in idiopathic cystic bronchiectasis'. Together they form a unique fingerprint.

Cite this

@article{5c731d26647049e48304aff8c97d24a7,

title = "Achromobacter xylosoxidans in idiopathic cystic bronchiectasis",

abstract = "This is the first case in the English language describing Achromobacter xylosoxidans in a patient with idiopathic bronchiectasis. A 66-year-old man with bronchiectasis presented with shortness of breath to the emergency department of our institution, a district hospital in the UK. His medications included long-term supplemental oxygen therapy and prophylactic azithromycin. Following 2 days admission to the respiratory unit, his saturations significantly deteriorated, and the patient was admitted to intensive care with type II respiratory failure. Following a week of intubation and ventilation, multidrug resistant A. xylosoxidans was isolated from the tracheal aspiration secretions. The patient recovered after receiving targeted intravenous antimicrobial therapy.",

keywords = "Achromobacter denitrificans, Aged, Anti-Bacterial Agents/administration & dosage, Bronchiectasis/drug therapy, Gram-Negative Bacterial Infections/drug therapy, Humans, Male",

author = "Bates, {Anthony Simon} and Manjula Natarajan and Reddy, {Raja Vongala}",

note = "{\textcopyright} BMJ Publishing Group Limited 2018. No commercial re-use. See rights and permissions. Published by BMJ.",

year = "2018",

month = nov,

doi = "10.1136/bcr-2015-211610",

language = "English",

volume = "11",

journal = "BMJ Case Reports",

issn = "1757-790X",

publisher = "BMJ Publishing Group",

number = "1",

}

TY - JOUR

T1 - Achromobacter xylosoxidans in idiopathic cystic bronchiectasis

AU - Bates, Anthony Simon

AU - Natarajan, Manjula

AU - Reddy, Raja Vongala

N1 - © BMJ Publishing Group Limited 2018. No commercial re-use. See rights and permissions. Published by BMJ.

PY - 2018/11

Y1 - 2018/11

N2 - This is the first case in the English language describing Achromobacter xylosoxidans in a patient with idiopathic bronchiectasis. A 66-year-old man with bronchiectasis presented with shortness of breath to the emergency department of our institution, a district hospital in the UK. His medications included long-term supplemental oxygen therapy and prophylactic azithromycin. Following 2 days admission to the respiratory unit, his saturations significantly deteriorated, and the patient was admitted to intensive care with type II respiratory failure. Following a week of intubation and ventilation, multidrug resistant A. xylosoxidans was isolated from the tracheal aspiration secretions. The patient recovered after receiving targeted intravenous antimicrobial therapy.

AB - This is the first case in the English language describing Achromobacter xylosoxidans in a patient with idiopathic bronchiectasis. A 66-year-old man with bronchiectasis presented with shortness of breath to the emergency department of our institution, a district hospital in the UK. His medications included long-term supplemental oxygen therapy and prophylactic azithromycin. Following 2 days admission to the respiratory unit, his saturations significantly deteriorated, and the patient was admitted to intensive care with type II respiratory failure. Following a week of intubation and ventilation, multidrug resistant A. xylosoxidans was isolated from the tracheal aspiration secretions. The patient recovered after receiving targeted intravenous antimicrobial therapy.

KW - Achromobacter denitrificans

KW - Aged

KW - Anti-Bacterial Agents/administration & dosage

KW - Bronchiectasis/drug therapy

KW - Gram-Negative Bacterial Infections/drug therapy

KW - Humans

KW - Male

U2 - 10.1136/bcr-2015-211610

DO - 10.1136/bcr-2015-211610

M3 - Article

C2 - 30567079

VL - 11

JO - BMJ Case Reports

JF - BMJ Case Reports

SN - 1757-790X

IS - 1

M1 - e211610

ER -